Prostate-specific antigen levels in rural men
Part of Cancer, Kidney & urinary clinical trials.
This study checks the level of a protein called PSA (prostate-specific antigen) in the blood of men living in rural areas. It helps understand normal PSA levels in this group, which may aid in early detection of prostate problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be male.
- You must be 55 years old or older.
- You must not have had any treatment for prostate issues in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test to look for microRNA patterns that may help spot prostate cancer earlier and avoid unnecessary biopsies. If you have elevated PSA or suspicious findings, this test might give more information about your risk.
This study aims to find normal PSA (prostate-specific antigen) levels for trans and non-binary people who have a prostate and are on hormone therapy or have had certain surgeries. Your participation could help improve future cancer screening guidelines for your community.
This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.
This study uses a blood test to detect prostate cancer more accurately than traditional methods. It looks for genetic material from cancer cells to help decide if a prostate biopsy is needed.
This study tests a new scanning method (rhPSMA-7.3 PET/CT) to detect prostate cancer recurrence when PSA is slightly high. If your PSA is low but rising, and standard scans haven't found cancer, this scan might help locate it.
This study uses a blood filtering procedure (apheresis) to collect prostate cancer cells from your blood for detailed analysis. It may help researchers understand why some prostate cancers spread, which could lead to better treatments. There are three groups: men with metastatic prostate cancer, men with PSA relapse after prostatectomy, and healthy volunteers.
Hear when a new Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.